To view this email as a web page, click here.

NEW THERAPIES
 
HIV dual therapy shows promise
A dual-drug regimen to treat HIV could soon be a reality, according to results presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle.
Read more
 
Tests help aid in antibiotic control
Find out how 2 new FDA-approved tests will help healthcare providers determine which antibiotics are needed, leading to better antibiotics management.
Read more
 
CONTINUING PHARMACY EDUCATION
 
Human papillomavirus (HPV) vaccine: updated recommendations and strategies to improve
This month's CE activity, "Human papillomavirus (HPV) vaccine: updated recommendations and strategies to improve," is open for pharmacists and pharmacy technicians.

The goal of this activity is to educate pharmacists and pharmacy technicians about the updated recommendations for the human papillomavirus (HPV) vaccine and ways that they can help improve adherence and vaccination rates in their community.

Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics.
More
 
EDITOR'S PICK
 
Will Trump's FDA picks speed drug approval?
Three candidates whom President Trump is considering for FDA commissioner are likely to speed drug approvals, analysts say.
Read more
 
RELATED ARTICLES
 
Multidrug-resistant HIV drug on horizon
FDA: antibiotics class must carry warning
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.